Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

309 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of relapsed precursor-B acute lymphoblastic leukemia with intensive chemotherapy: POG (Pediatric Oncology Group) study 9411 (SIMAL 9).
Kelly ME, Lu X, Devidas M, Camitta B, Abshire T, Bernstein ML, Billett A, Homans A, Sandler E, Buchanan G. Kelly ME, et al. Among authors: camitta b. J Pediatr Hematol Oncol. 2013 Oct;35(7):509-13. doi: 10.1097/MPH.0b013e31829f3235. J Pediatr Hematol Oncol. 2013. PMID: 23887024 Free PMC article. Clinical Trial.
Intensified PEG-L-asparaginase and antimetabolite-based therapy for treatment of higher risk precursor-B acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Salzer WL, Devidas M, Shuster JJ, Wang C, Chauvenet A, Asselin BL, Camitta BM, Kurtzberg J; Children's Oncology Group. Salzer WL, et al. J Pediatr Hematol Oncol. 2007 Jun;29(6):369-75. doi: 10.1097/MPH.0b013e3180640d54. J Pediatr Hematol Oncol. 2007. PMID: 17551397 Clinical Trial.
Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866).
Kurtzberg J, Asselin B, Bernstein M, Buchanan GR, Pollock BH, Camitta BM. Kurtzberg J, et al. Among authors: camitta bm. J Pediatr Hematol Oncol. 2011 Dec;33(8):610-6. doi: 10.1097/MPH.0b013e31822d4d4e. J Pediatr Hematol Oncol. 2011. PMID: 22042277 Free PMC article. Clinical Trial.
Dose intensification of methotrexate and cytarabine during intensified continuation chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: POG 9406: a report from the Children's Oncology Group.
Tower RL, Jones TL, Camitta BM, Asselin BL, Bell BA, Chauvenet A, Devidas M, Halperin EC, Pullen J, Shuster JJ, Winick N, Kurtzberg J. Tower RL, et al. J Pediatr Hematol Oncol. 2014 Jul;36(5):353-61. doi: 10.1097/MPH.0000000000000131. J Pediatr Hematol Oncol. 2014. PMID: 24608079 Free PMC article. Clinical Trial.
Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research.
Eapen M, Raetz E, Zhang MJ, Muehlenbein C, Devidas M, Abshire T, Billett A, Homans A, Camitta B, Carroll WL, Davies SM; Children's Oncology Group; Center for International Blood and Marrow Transplant Research. Eapen M, et al. Among authors: camitta b. Blood. 2006 Jun 15;107(12):4961-7. doi: 10.1182/blood-2005-12-4942. Epub 2006 Feb 21. Blood. 2006. PMID: 16493003 Free PMC article.
Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: results of Children's Oncology Group trial P9906.
Bowman WP, Larsen EL, Devidas M, Linda SB, Blach L, Carroll AJ, Carroll WL, Pullen DJ, Shuster J, Willman CL, Winick N, Camitta BM, Hunger SP, Borowitz MJ. Bowman WP, et al. Among authors: camitta bm. Pediatr Blood Cancer. 2011 Oct;57(4):569-77. doi: 10.1002/pbc.22944. Epub 2011 Feb 25. Pediatr Blood Cancer. 2011. PMID: 21360654 Free PMC article. Clinical Trial.
309 results